Japanese billionaire Mikitani takes full control of Rakuten Aspyrian; HOX Therapeutics taps Karl Keegan as CEO
→ Having infused $150 million into Rakuten Aspyrian weeks ago, Hiroshi “Mickey” Mikitani is stepping up his control on the biotech he’s been chairing since 2016. The Japanese billionaire, known for building a legendary e-tailer from scratch, is taking over the CEO role so that Miguel Garcia-Guzman can continue to build the photoimmunotherapy pipeline as CSO and vice chairman. As the San Diego-based company turns the corner on a Phase III study, it’s also appointed Takashi Toraishi, who was managing its Japan offices, as COO to oversee clinical trials and commercialization.
Unlock this article instantly by becoming a free subscriber.
You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.